Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
C$0.74
N/AN/A1.42 million shsN/A
Convergys Co. stock logo
CVG
Convergys
$24.41
$24.41
$21.13
$26.72
N/AN/A1.10 million shsN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
C$285.00
C$297.62
C$280.00
C$327.51
C$703.95M0.81290 shsN/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
Convergys Co. stock logo
CVG
Convergys
0.00%0.00%0.00%0.00%0.00%
Senvest Capital Inc. stock logo
SEC
Senvest Capital
0.00%0.00%0.00%-12.31%-5.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Convergys Co. stock logo
CVG
Convergys
N/AN/AN/AN/AN/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ATT
Abattis Bioceuticals
N/AN/AN/AN/A
Convergys Co. stock logo
CVG
Convergys
N/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
Convergys Co. stock logo
CVG
Convergys
N/AN/AN/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
C$612.76M1.15C$1,478.98 per share0.19C$634.25 per share0.45

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ATT
Abattis Bioceuticals
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Convergys Co. stock logo
CVG
Convergys
N/A$1.8812.98N/AN/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
C$151.74M-C$84.10N/AN/A24.76%10.04%6.62%5/14/2024 (Estimated)

Latest APAX, CVG, ATT, SEC, and RICA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AC$34.61+C$34.61C$34.61N/AC$166.73 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A
Convergys Co. stock logo
CVG
Convergys
$0.441.80%N/A23.40%N/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ATT
Abattis Bioceuticals
N/AN/AN/A
Convergys Co. stock logo
CVG
Convergys
N/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
56.89
1.35
1.31

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ATT
Abattis Bioceuticals
N/A
Convergys Co. stock logo
CVG
Convergys
N/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/A

Insider Ownership

CompanyInsider Ownership
ATT
Abattis Bioceuticals
N/A
Convergys Co. stock logo
CVG
Convergys
1.70%
Senvest Capital Inc. stock logo
SEC
Senvest Capital
60.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable
Convergys Co. stock logo
CVG
Convergys
N/AN/AN/AOptionable
Senvest Capital Inc. stock logo
SEC
Senvest Capital
322.47 millionN/ANot Optionable

APAX, CVG, ATT, SEC, and RICA Headlines

SourceHeadline
Cornerstone investment regulations issued by SECCornerstone investment regulations issued by SEC
msn.com - April 26 at 12:57 PM
SEC sued over Ethereum, crypto firm asks court to state token is not a securitySEC sued over Ethereum, crypto firm asks court to state token is not a security
msn.com - April 26 at 7:57 AM
SEC Unveils Groundbreaking Report Revealing $26 Trillion in Registered Funds to Foster TransparencySEC Unveils Groundbreaking Report Revealing $26 Trillion in Registered Funds to Foster Transparency
hoodline.com - April 26 at 7:57 AM
Regulators Impose Extraordinary Fine Amounts in Recent Off-Channel Communications Enforcement ActionsRegulators Impose Extraordinary Fine Amounts in Recent Off-Channel Communications Enforcement Actions
jdsupra.com - April 24 at 8:49 PM
SEC Settles Charges with Investment Adviser for Off-Channel Communications Recordkeeping FailuresSEC Settles Charges with Investment Adviser for Off-Channel Communications Recordkeeping Failures
jdsupra.com - April 24 at 8:49 PM
Fund offering ‘venture capital’ exposure sends investors on meme-like rideFund offering ‘venture capital’ exposure sends investors on meme-like ride
kfgo.com - April 24 at 12:09 AM
Senvest Management Enforcement Action – Electronic CommunicationsSenvest Management Enforcement Action – Electronic Communications
jdsupra.com - April 15 at 11:12 PM
SATRIX Collective Investment Scheme Expands Portfolio with New Securities ListingSATRIX Collective Investment Scheme Expands Portfolio with New Securities Listing
msn.com - April 12 at 10:22 AM
SEC to sue Uniswap DEX amid DeFi regulatory crackdownSEC to sue Uniswap DEX amid DeFi regulatory crackdown
financefeeds.com - April 11 at 1:45 PM
SEC Warns DeFi Firm Uniswap Labs of Potential LawsuitSEC Warns DeFi Firm Uniswap Labs of Potential Lawsuit
wsj.com - April 10 at 6:02 PM
Affinius Capital warns new SEC rules will have significant effect on operationsAffinius Capital warns new SEC rules will have 'significant effect' on operations
bizjournals.com - April 9 at 8:48 PM
FINRA Fines Florida B/D $500K For Not Retaining Business-Related TextsFINRA Fines Florida B/D $500K For Not Retaining Business-Related Texts
wealthmanagement.com - April 8 at 2:13 PM
SEC Charges Advisory Firm Senvest Management with Recordkeeping and Other FailuresSEC Charges Advisory Firm Senvest Management with Recordkeeping and Other Failures
tradersmagazine.com - April 5 at 4:56 AM
Global View Capital Advisors Selects OneVest as its Wealth Management Platform PartnerGlobal View Capital Advisors Selects OneVest as its Wealth Management Platform Partner
tmcnet.com - April 4 at 6:56 PM
Senvest latest rapped by SEC over off-channel commsSenvest latest rapped by SEC over off-channel comms
complianceweek.com - April 4 at 3:53 AM
RIA Senvest To Pay $6.5M for Text Message Record-Keeping FailuresRIA Senvest To Pay $6.5M for Text Message Record-Keeping Failures
wealthmanagement.com - April 3 at 5:52 PM
Senvest Capital Reports Results for the Year Ended December 31, 2023Senvest Capital Reports Results for the Year Ended December 31, 2023
finance.yahoo.com - March 28 at 7:38 PM
Why did this prime Palm Beach condo sell for $11.93M, about $3M less than 2022 sale?Why did this prime Palm Beach condo sell for $11.93M, about $3M less than 2022 sale?
palmbeachdailynews.com - March 27 at 3:41 PM
Vibrant Capital Market Vital For Economy - SECVibrant Capital Market Vital For Economy - SEC
msn.com - March 23 at 10:13 AM
SPDR S&P Capital Markets ETF declares quarterly distribution of $0.5558SPDR S&P Capital Markets ETF declares quarterly distribution of $0.5558
msn.com - March 18 at 1:14 PM
SEC climate disclosure rule faces legal gantletSEC climate disclosure rule faces legal gantlet
eenews.net - March 11 at 7:17 PM
Starwood Capital Entities and Jaws Mustang Acquisition sign non-binding LOIStarwood Capital Entities and Jaws Mustang Acquisition sign non-binding LOI
msn.com - March 11 at 2:16 PM
Satrix Collective Investment Scheme Adds New Securities to JSE ListingSatrix Collective Investment Scheme Adds New Securities to JSE Listing
msn.com - March 11 at 9:16 AM
Transcend Capital Advisors Adds Elite Amateur Blades Brown To NIL RosterTranscend Capital Advisors Adds Elite Amateur Blades Brown To NIL Roster
businesswire.com - March 7 at 8:48 PM

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abattis Bioceuticals

CNSX:ATT
Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.
Convergys logo

Convergys

NYSE:CVG
Convergys Corporation provides customer management services to communications and media, technology, financial services, retail, healthcare, government, travel and hospitality, and other vertical markets worldwide. The company offers solutions across the customer lifecycle, including sales, customer service, technical support, customer retention, and collection, as well as security, compliance, and fraud solutions; and solutions in contact center technology comprising omni-channel interaction, cross-channel integration framework, real-time decisioning engine, robotic process automation, intelligent notification, campaign management, personalized care, personalized selling, agent productivity, and retention solutions. It also provides analytics and consulting, and software solutions, such as enterprise feedback management, integrated customer experience analytics, post-contact surveys, relational loyalty research, customer segmentation and profiling, call elimination analysis, analysis of customer effort, digital channel optimization, and integrated contact center analytics solutions, as well as voice of customer software. The company operates through 140 contact centers. Convergys Corporation was founded in 1998 and is headquartered in Cincinnati, Ohio.
Senvest Capital logo

Senvest Capital

TSE:SEC
Senvest Capital Inc., through its subsidiaries, holds investments in equity and real estate holdings in the United States and internationally. The company invests in derivative financial instruments comprising primarily options and warrants to purchase or sell equities, equity indices and currencies, equity swaps, foreign currency forward contracts, and foreign currency futures contracts. It also has investments as minority interests in private entities whose main assets are real estate properties; and real estate income trusts and partnerships. In addition, the company invests in self-storage facilities in Spain. The company was formerly known as Sensormatic Canada Limited and changed its name to Senvest Capital Inc. in April 1991. Senvest Capital Inc. was incorporated in 1968 and is headquartered in Montreal, Canada.